Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective, multicentre, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of a 0.005% estriol vaginal gel in the prevention of recurrent urinary tract infections in postmenopausal women with vaginal atrophy. ("BLISSURE study" Ensayo clínico prospectivo, multicéntrico, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia de un gel vaginal de estriol al 0,005% en la prevención de infecciones del tracto urinario recurrentes en mujeres postmenopáusicas con atrofia vaginal. "Estudio BLISSURE")

Next Previous
Trial Profile

Prospective, multicentre, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of a 0.005% estriol vaginal gel in the prevention of recurrent urinary tract infections in postmenopausal women with vaginal atrophy. ("BLISSURE study" Ensayo clínico prospectivo, multicéntrico, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia de un gel vaginal de estriol al 0,005% en la prevención de infecciones del tracto urinario recurrentes en mujeres postmenopáusicas con atrofia vaginal. "Estudio BLISSURE")

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Nov 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estriol succinate (Primary)
  • Indications Atrophic vaginitis
  • Focus Therapeutic Use
  • Acronyms BLISSURE
  • Sponsors Itf Research Pharma

Most Recent Events

  • 20 Nov 2024 Results assessing efficacy of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause published in the Maturitas
  • 04 Dec 2018 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top